Addex Therapeutics (ADXN) Treasury Shares (2018 - 2026)
Addex Therapeutics (ADXN) posted Treasury Shares of -$1.3 million for Q1 2026, down 0.79% sequentially from -$1.3 million in Q4 2025, and down 32.38% YoY from -$1.9 million in Q1 2025.
Addex Therapeutics (ADXN) Treasury Shares (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Treasury Shares for 9 years, with the latest figure at -$1.3 million in Q1 2026.
- Quarterly Treasury Shares fell 32.38% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 32.38% YoY) and the FY2025 annual result came in at -$1.2 million, down 223.83% from the prior year.
- Treasury Shares slipped to -$1.3 million in Q1 2026 per ADXN's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $88.6 million in Q4 2025 and troughed at -$60.7 billion in Q3 2023.
- A 5-year average of -$7.9 billion and a median of $22.5 million in 2021 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 97.54% in 2023, then tumbled 227.91% in 2025.
- Over 5 years, Treasury Shares stood at $6.5 million in 2022, then sank by 84.27% to $1.0 million in 2023, then declined by 3.18% to $992790.7 in 2024, then slumped by 227.91% to -$1.3 million in 2025, then retreated by 0.79% to -$1.3 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered -$1.3 million, -$1.3 million, and -$855411.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 Mn |
| Mar 31, 2026 | -1.28 Mn |
| Dec 31, 2025 | 88.61 Mn |
| Dec 31, 2025 | 88.61 Mn |
| Dec 31, 2025 | -1.27 Mn |
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | -855,411.19 |
| Sep 30, 2025 | -855,411.19 |
| Jun 30, 2025 | 52.14 Mn |
| Jun 30, 2025 | 52.14 Mn |
| Jun 30, 2025 | -892,013.65 |
| Jun 30, 2025 | -892,013.65 |
| Mar 31, 2025 | -966,881.62 |
| Mar 31, 2025 | -966,881.62 |
| Dec 31, 2024 | 64.00 Mn |
| Dec 31, 2024 | 64.00 Mn |
| Dec 31, 2024 | 992,790.68 |
| Dec 31, 2024 | 992,790.68 |
| Sep 30, 2024 | -1.01 Mn |
| Sep 30, 2024 | -1.01 Mn |